Results 21 to 30 of about 29,491 (205)
Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
Pharmaceuticals, 2022 As the third leading cause of cancer death worldwide, hepatocellular carcinoma (HCC) is characterized by late detection, difficult diagnosis and treatment, rapid progression, and poor prognosis.
Ruiqi Liu +4 more
doaj +1 more source
A brief overview of targeted radionuclide therapy trials in 2022
Frontiers in Nuclear Medicine, 2023 There is a growing use of radionuclide therapy for the medical care of oncology patients, where radioactive pharmaceuticals are used to target and treat various cancer types.
Aidan Healy +3 more
doaj +1 more source
World Journal of Nuclear Medicine, 2020 Prostate-specific membrane antigen (PSMA) is a Type II transmembrane glycoprotein which is extremely overexpressed in prostate cancer epithelial cells. Recently, PSMA-targeted small molecule labeled with 68Ga and 99mTc allowed precise molecular imaging ...
Esmail Jafari +3 more
doaj +1 more source
Radioprotective Effect of Beta D-Glucan and Vitamin E on Gamma Irradiated Mouse [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: It is shown that beta-D-glucan is an immunologic system booster with radioprotectory effects. Radioprotectors are chemical components that can alleviate biological damage produced by ionizing radiation.
Faraj Tabeie +3 more
doaj +1 more source
Theragnostic Radionuclide Pairs for Prostate Cancer Management: 64Cu/67Cu, Can Be a Budding Hot Duo
Biomedicines, 2022 Prostate cancer (PCa) is one of the preeminent causes of mortality in men worldwide. Theragnostic, a combination of therapy and diagnostic, using radionuclide pairs to diagnose and treat disease, has been shown to be a promising approach for combating ...
Anupriya Chhabra, Mathew L. Thakur
doaj +1 more source
Management of biological waste of patients after radionuclide therapy
Радиационная гигиена, 2022 Radioactive waste management is a modern-day issue in terms of radiation safety due to the development of radionuclide therapy, the emergence of new radiopharmaceuticals, radionuclides, and treatment methods, which allow for radionuclide therapy in a day
L. A. Chipiga +7 more
doaj +1 more source
Peptide Receptor Radionuclide Therapy [PDF]
Best Practice & Research Clinical Gastroenterology, 2004 Abstract: On their plasma membranes, cells express receptor proteins with high affinity for regulatory peptides, such as somatostatin. Changes in the density of these receptors during disease, for example, overexpression in many tumors, provide the basis for new imaging methods.
Krenning, Eric +5 more
openaire +5 more sources
World Journal of Nuclear Medicine, 2015 Tumoral calcinosis (TC) is an uncommon ectopic calcification syndrome. TC is a benign condition characterized by the presence of large calcific soft tissue deposits occurring predominantly in a periarticular location.
Koramadai Kamaleshwaran +4 more
doaj +1 more source
World Journal of Nuclear Medicine, 2018 Renal cell carcinoma (RCC) of the native kidney accounts for
Koramadai Kamaleshwaran +3 more
doaj +1 more source
Radionuclides for Targeted Therapy: Physical Properties
Molecules, 2022 A search in PubMed revealed that 72 radionuclides have been considered for molecular or functional targeted radionuclide therapy. As radionuclide therapies increase in number and variations, it is important to understand the role of the radionuclide and ...
Caroline Stokke +2 more
doaj +1 more source